Not everyone with IgA nephropathy will need steroids, but for some, these medications can help protect kidney function.
Few randomized, controlled trials have investigated the efficacy of pharmacological treatment for lymphocytic colitis. Data from a new randomized, placebo-controlled trial have demonstrated the ...
Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared Eohilia ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
With Florida’s subtropical climate supporting continuous pollen production, Southwest Florida residents battle allergy symptoms year around. “Peak allergy season in Southwest Florida typically occurs ...
MedPage Today on MSN
Complement inhibitor slowed kidney decline in IgA nephropathy
Continued FDA approval of iptacopan was contingent on 2-year trial data ...
CytomX Therapeutics’ latest earnings call struck an upbeat tone as management highlighted robust efficacy signals, improving safety, and a clearer path toward registration for Varseta‑M in metastatic ...
Only dupilumab (Dupixent), cendakimab, and budesonide oral suspension and orodispersible tablets for eosinophilic esophagitis ...
The eosinophilic esophagitis market is witnessing steady growth, primarily driven by the increasing awareness leading to standardized diagnosis and high relapse rates that continue to fuel ongoing ...
My husband has been suffering from tinnitus for a couple of years now. His primary care physician referred him to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results